CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
Cannabis Bioscience International Holdings, Inc.
Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026
$0.00+0.00 (+33.33%)
Close on Oct 19, 2026
- Market cap
- $2.33M
- P/E (TTM)
- –
- Dividend yield
- –
Cannabis Bioscience International Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Trials [Member] | $110.88K | $114.61K | $147.48K | $301.73K | $330.40K | $351.07K | $329.29K | $213.87K | $187.50K | $193.89K | $212.63K | $267.22K | 89.7% | -66.4% |
| Merchandise [Member] | $461 | $456 | $851 | $1.29K | $1.56K | $2.37K | $3.33K | $4.41K | $24.44K | $23.76K | $30.61K | $22.30K | 0.4% | -70.4% |
| Seminar Fees [Member] | – | – | – | $0 | – | – | – | $1.93K | – | – | – | $16.43K | – | – |
| Consulting Fees [Member] | – | – | – | $0 | $11.97K | $11.97K | $20.31K | $28.64K | $25.00K | $25.00K | – | $8.33K | – | – |
By region
From the segment and revenue-disaggregation notes of Cannabis Bioscience International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.